In response to dengue virus infection, the GM-MDM cells use CLEC5A as an innate immune receptor, and this CLEC5A/DAP12 innate immune response is facilitated by the high avidity glycan binding receptors MR and DC-SIGN in proximity to form a hetero-multivalent complex. Here, CD209 is linked to dengue disease.